Technical Analysis for NTRB - Nutriband Inc.
Grade | Last Price | % Change | Price Change |
---|---|---|---|
D | 4.98 | 1.43% | 0.07 |
NTRB closed up 1.43 percent on Wednesday, November 20, 2024, on 39 percent of normal volume. It was able to bounce off of its 200 day moving average, an important long-term support line. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
Earnings due: Dec 10
*** please verify all earnings dates ***ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Strong | Up | Down | Down |
Date | Alert Name | Type | % Chg |
---|---|---|---|
200 DMA Support | Bullish | 0.00% | |
Inside Day | Range Contraction | 0.00% | |
Wide Bands | Range Expansion | 0.00% | |
Oversold Stochastic | Weakness | 0.00% | |
200 DMA Support | Bullish | 1.43% | |
Wide Bands | Range Expansion | 1.43% | |
Gapped Down | Weakness | 1.43% | |
Oversold Stochastic | Weakness | 1.43% | |
Crossed Above 200 DMA | Bullish | 0.40% | |
Wide Bands | Range Expansion | 0.40% |
Alert | Time |
---|---|
200 DMA Support | about 21 hours ago |
10 DMA Resistance | about 21 hours ago |
Up 3% | about 21 hours ago |
Down 2 % | about 21 hours ago |
Down 1% | about 21 hours ago |
Get a Trading Assistant
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 12/10/2024
The Company is primarily engaged in the development of a portfolio of transdermal pharmaceutical products. Its lead product under development is its abuse deterrent fentanyl transdermal system which the Company is developing to provide clinicians and patients with an abuse deterrent transdermal fentanyl product for use in managing chronic pain requiring opioid therapy. The product is combined with properties designed to help combat the opioid crisis by deterring the abuse and misuse of fentanyl patches
Sector: Healthcare
Industry: Biotechnology
Keywords: Euphoriants Opioids Chronic Pain Analgesics Heroin Morphine Fentanyl Anilides Semisynthetic Opioids
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Euphoriants Opioids Chronic Pain Analgesics Heroin Morphine Fentanyl Anilides Semisynthetic Opioids
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 9.595 |
52 Week Low | 2.22 |
Average Volume | 33,305 |
200-Day Moving Average | 4.88 |
50-Day Moving Average | 5.93 |
20-Day Moving Average | 5.46 |
10-Day Moving Average | 5.01 |
Average True Range | 0.48 |
RSI (14) | 40.48 |
ADX | 26.67 |
+DI | 12.20 |
-DI | 23.02 |
Chandelier Exit (Long, 3 ATRs) | 4.96 |
Chandelier Exit (Short, 3 ATRs) | 6.07 |
Upper Bollinger Bands | 6.53 |
Lower Bollinger Band | 4.40 |
Percent B (%b) | 0.27 |
BandWidth | 39.05 |
MACD Line | -0.36 |
MACD Signal Line | -0.30 |
MACD Histogram | -0.0552 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 5.45 | ||||
Resistance 3 (R3) | 5.44 | 5.27 | 5.37 | ||
Resistance 2 (R2) | 5.27 | 5.15 | 5.28 | 5.34 | |
Resistance 1 (R1) | 5.13 | 5.08 | 5.20 | 5.14 | 5.32 |
Pivot Point | 4.96 | 4.96 | 5.00 | 4.97 | 4.96 |
Support 1 (S1) | 4.82 | 4.84 | 4.89 | 4.83 | 4.64 |
Support 2 (S2) | 4.65 | 4.77 | 4.66 | 4.62 | |
Support 3 (S3) | 4.51 | 4.65 | 4.59 | ||
Support 4 (S4) | 4.52 |